Skip to content

Pharmarise Holdings Co., Ltd.

Japanese holding company operating a nationwide chain of dispensing pharmacies and drugstores under the Pharmarise brand.

Last updated September 27, 2026

AI crawler reads

No AI crawler has read this profile since Oct 28, 2026.

Overview

Pharmarise Holdings Co., Ltd. is a Japanese corporate group whose core business is the operation of insurance dispensing pharmacies (調剤薬局) and related health-retail formats. The company was founded on 1 June 1984 and has built its identity around the corporate motto "Perfect" (パーフェクト), positioning itself as a community healthcare partner that supports patients' health and wellbeing. Its main operating subsidiary, Pharmarise Co., Ltd., runs dispensing pharmacies, drugstores, a cosmetics store and acupuncture/massage clinics across Japan; as of 1 June 2026 the group reported 227 dispensing pharmacies, 41 drugstores, one cosmetics store and five acupuncture/massage clinics under that subsidiary alone, with additional regional subsidiaries operating pharmacies in areas such as Tokai, Kansai, Hokkaido, Kyushu, Okinawa and the Kanto region. The group's business model centres on insurance dispensing — filling prescriptions under Japan's national health insurance system — combined with self-medication support through over-the-counter medicines, supplements and health foods, and services such as online medication guidance, home-visit pharmaceutical care and health-support pharmacy programmes. Management has emphasised adaptation to Japan's ageing society, the promotion of medical DX including My Number Card online eligibility verification and electronic prescriptions, and active participation in M&A to consolidate a fragmented pharmacy market. Pharmarise Holdings is listed on the Tokyo Stock Exchange. It was listed on the JASDAQ market on 21 February 2007, moved to the Second Section on 17 February 2014, to the First Section on 21 January 2015, and to the Standard Market on 20 October 2023 following the exchange's market restructuring. The company has also disclosed sustainability commitments, including identification of materiality and endorsement of the TCFD recommendations in August 2023. Its leadership includes Chairman Toshimichi Ono and President Masayuki Akiyama, and the group continues to pursue growth through new store openings, acquisitions and expanded health services as it approaches its 50th anniversary.

History

Pharmarise Holdings traces its origins to 1 June 1984, when the business was founded in Japan. From the outset the company adopted the corporate motto "Perfect" (パーフェクト) and built its operations around dispensing pharmacy services as Japan's separation of prescribing and dispensing (医薬分業) expanded. Over the following decades the group grew into a nationwide network through a combination of new store openings and acquisitions of regional pharmacy operators. A major turning point came on 21 February 2007, when the company listed its shares on the JASDAQ market of the Tokyo Stock Exchange. It subsequently moved to the exchange's Second Section on 17 February 2014 and to the First Section on 21 January 2015, reflecting its growing scale. On 20 October 2023, following the Tokyo Stock Exchange's market restructuring, the company's shares were moved to the Standard Market, where they continue to trade. Through the 2010s and 2020s the group expanded its regional footprint by acquiring and integrating pharmacy chains across Japan. Its consolidated subsidiaries have included Pharmarise Co., Ltd. (the main operating company), Tokai Pharmarise, Kansai Pharmarise, Hokkaido Pharmarise, Futaba, Kawaguchi Pharmacy, Shinsai Yakuhin, Ethics, Dream, Yaku-Higuchi & Pharmarise, Four You, and others, giving the group dispensing pharmacies and drugstores in regions ranging from Hokkaido and the Kanto area to Tokai, Kansai, Kyushu and Okinawa. The group also diversified into adjacent businesses such as medical record off-site storage through Kotobuki Data Bank and cosmetics and wellness retail. In August 2023 the company disclosed the identification of materiality and its endorsement of the TCFD recommendations, signalling a formal commitment to sustainability. Management has continued to emphasise adaptation to Japan's ageing population and declining working-age population, promoting medical DX initiatives such as My Number Card-based online eligibility verification and electronic prescriptions, online medication guidance, and home-visit pharmaceutical care. The company has also stated its intention to continue pursuing M&A as a core growth strategy. As of 2026 the group reported 227 dispensing pharmacies, 41 drugstores, one cosmetics store and five acupuncture/massage clinics under its main subsidiary, and it has described its ambition to continue challenging itself toward its 50th anniversary.

  • Company founded in Japan.

  • Listed on the JASDAQ market of the Tokyo Stock Exchange.

  • Moved to the Second Section of the Tokyo Stock Exchange.

  • Moved to the First Section of the Tokyo Stock Exchange.

  • Disclosed identification of materiality and endorsement of TCFD recommendations.

  • Moved to the Standard Market of the Tokyo Stock Exchange.

  • Reported 227 dispensing pharmacies, 41 drugstores, one cosmetics store and five acupuncture/massage clinics under main subsidiary Pharmarise Co., Ltd.

Products and positioning

Community healthcare partner providing dispensing pharmacy and self-medication support services across Japan.

  • Insurance dispensing pharmacy services

  • Drugstore retail

  • Over-the-counter medicines and supplements

  • Health foods

  • Cosmetics retail

  • Acupuncture and massage services

  • Online medication guidance

  • Home-visit pharmaceutical care

  • Medical record off-site storage

Sources5 sources

Cite this profile: Cite the canonical profile. /brand-wiki/pharmarise-holdings · Editorial policy · How profiles are compiled